Hemorrhagic Transformation
- Hemorrhagic transformation is when a stroke that started as a plumbing problem (no blood getting in) turns into a bleeding problem — blood leaking into the already-injured tissue.
- It happens because the dead/dying brain's blood vessels are leaky, and it gets worse when blood flow returns (reperfusion) or after clot-busting drugs like tPA.
- The spectrum runs from harmless little petechial specks (HI: hemorrhagic infarction) to a big, mass-effect-causing clot (PH: parenchymal hematoma).
- The key question is never just "is there blood?" but "is this bleed within the infarct and is it big enough to hurt the patient?"
You spend the first half of a stroke worrying that blood isn't getting somewhere. Then, cruelly, the second half can flip on you: blood shows up where it shouldn't, inside the very area you were worried about. That plot twist is hemorrhagic transformation, and it's one of the more important "wait, this got worse" moments in neuro.
What's actually happening
Start with an ischemic stroke: an artery clogs, and the brain downstream starts starving. Now picture the walls of the tiny blood vessels in that starving zone as a garden hose that's been left out in the sun for three summers — brittle, cracked, and leaky. The cells that normally keep the vessel wall watertight (the blood-brain barrier) are injured too.
So the vessels are fragile. The trigger is when pressure or flow comes back. This is the cruel irony of reperfusion: you finally reopen the clogged artery — exactly what you wanted — and the restored blood pressure pushes red cells out through those cracked walls. Good blood, bad pipes.
This is why hemorrhagic transformation isn't a separate disease — it's a complication of the infarct you already have. The blood lives inside the territory that died. That location, conforming to a vascular territory, is your biggest clue that you're looking at transformation rather than a primary bleed.
The spectrum: from freckles to a fist
Not all blood is created equal, and radiologists sort it along a spectrum. On one end you have faint, scattered petechial dots smeared along the cortex — think of someone flicking a paintbrush. On the other end you have a dense, rounded clot with real bulk that shoves the brain around. The classic framework (from the stroke trials) splits it into two families:
| Type | Plain-English picture | Why you care |
|---|---|---|
| HI (hemorrhagic infarction) | Petechial blood speckled through the infarct, no mass effect | Usually clinically quiet; often expected, often fine |
| PH (parenchymal hematoma) | A confluent clot, sometimes with mass effect | This is the one that can crash the patient |
The dividing line that matters clinically is mass effect. Petechiae sit politely within the dead tissue. A parenchymal hematoma behaves like any space-occupying clot: it pushes, it swells, it can herniate. When people talk about the feared "symptomatic" hemorrhage after clot-busting drugs, they mean the big-clot end of this spectrum.
How you spot it
On non-contrast CT — the workhorse of the stroke pathway — fresh blood is bright (hyperdense), while the surrounding dead brain is dark (hypodense). So transformation looks like bright stuff splashed inside a dark wedge. The geography is the tell: the hemorrhage hugs the shape of the vascular territory, often loving the gray matter of the cortex and the deep gray nuclei (which are metabolically needy and bleed-prone).
MRI is more sensitive to tiny amounts of blood. Gradient-echo or susceptibility-weighted sequences (GRE/SWI) make even microscopic hemorrhage bloom into exaggerated black blobs — fantastic for catching petechiae you'd never see on CT.
Don't confuse hemorrhagic transformation with a primary intracranial hemorrhage (a bleed that was never an infarct). The discriminators: transformation lives inside a wedge-shaped, territory-conforming infarct, the blood is typically patchy and gyriform rather than a single round ball, and you usually have a clinical story of stroke first, deterioration second. A round hematoma centered in the basal ganglia with no preceding infarct is a primary bleed until proven otherwise.
Why anyone loses sleep over it
Two reasons. First, it changes the math on treatment. Reperfusion therapies — IV thrombolysis and thrombectomy — are wonderful precisely because they restore flow, but restoring flow to fragile vessels is also what provokes the worst bleeds. So the same intervention that saves the brain can, in a minority of patients, light up a hematoma. That tension is the entire reason the code stroke workflow is so obsessive about time windows, infarct size, and blood pressure.
A large infarct that's already visibly dark on early CT is at higher risk of bleeding if you reperfuse it — lots of dead, leaky tissue to push blood through. That's part of why a big, established infarct can argue against aggressive reperfusion. The bigger the dead zone, the bigger the potential mess.
Second, on a follow-up scan, transformation can masquerade as "the stroke got worse" when really the plumbing problem became a bleeding problem. Naming that correctly tells the team whether to keep thinning the blood or to slam on the brakes.
So the one line to carry out of here: hemorrhagic transformation is bleeding into a stroke you already have. Find the dark infarct, look for bright blood inside it, and then ask the only question that changes anything — is it petechial and quiet, or a clot with mass effect?